Viking Therapeutics (VKTX) Tops Q3 EPS by 1c

Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.20), $0.01 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance